Read + Share
Amedeo Smart
Independent Medical Education
Hartung HP, Benedict RHB, Berger T, Bermel RA, et al. Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial. Neurology 2024;103:e210049.PMID: 39626127
Email
LinkedIn
Privacy Policy